Abbott Laboratories - Stock

Abbott Laboratories ROE 2024

Abbott Laboratories ROE

0.15

Ticker

ABT

ISIN

US0028241000

WKN

850103

In 2024, Abbott Laboratories's return on equity (ROE) was 0.15, a -21.55% increase from the 0.19 ROE in the previous year.

Abbott Laboratories Aktienanalyse

What does Abbott Laboratories do?

Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Abbott Laboratories's Return on Equity (ROE)

Abbott Laboratories's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Abbott Laboratories's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Abbott Laboratories's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Abbott Laboratories’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Abbott Laboratories Stock

What is the ROE (Return on Equity) of Abbott Laboratories this year?

The ROE of Abbott Laboratories this year is 0.15 undefined.

How has the Return on Equity (ROE) of Abbott Laboratories developed compared to the previous year?

The ROE of Abbott Laboratories has increased by -21.55% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Abbott Laboratories?

A high ROE indicates that Abbott Laboratories generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Abbott Laboratories?

A low ROE can indicate that Abbott Laboratories is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Abbott Laboratories affect the company?

A change in ROE (Return on Equity) of Abbott Laboratories can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Abbott Laboratories?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Abbott Laboratories?

Some factors that can influence Abbott Laboratories's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Abbott Laboratories pay?

Over the past 12 months, Abbott Laboratories paid a dividend of 2.04 USD . This corresponds to a dividend yield of about 1.96 %. For the coming 12 months, Abbott Laboratories is expected to pay a dividend of 2.24 USD.

What is the dividend yield of Abbott Laboratories?

The current dividend yield of Abbott Laboratories is 1.96 %.

When does Abbott Laboratories pay dividends?

Abbott Laboratories pays a quarterly dividend. This is distributed in the months of November, February, May, August.

How secure is the dividend of Abbott Laboratories?

Abbott Laboratories paid dividends every year for the past 26 years.

What is the dividend of Abbott Laboratories?

For the upcoming 12 months, dividends amounting to 2.24 USD are expected. This corresponds to a dividend yield of 2.15 %.

In which sector is Abbott Laboratories located?

Abbott Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Abbott Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Abbott Laboratories from 8/15/2024 amounting to 0.55 USD, you needed to have the stock in your portfolio before the ex-date on 7/15/2024.

When did Abbott Laboratories pay the last dividend?

The last dividend was paid out on 8/15/2024.

What was the dividend of Abbott Laboratories in the year 2023?

In the year 2023, Abbott Laboratories distributed 1.88 USD as dividends.

In which currency does Abbott Laboratories pay out the dividend?

The dividends of Abbott Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Abbott Laboratories stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Abbott Laboratories

Our stock analysis for Abbott Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abbott Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.